Pinned Tweet
📢 Our paper is out!
We define CTHRC1-CAFs as #biomarker of response to #immunotherapy in MSS and MSI #CRC
Great teamwork @CalonLab @BatlleLab @mariglesiascoma
Thanks @ContraCancerEs for their support
🔗 gut.bmj.com/content/early/20…
Alexandre Calon retweeted
🧵We’re thrilled to share our latest collaborative work with the José Yélamos group and collaborators, now published in @ScienceAdvances! We uncover a previously unrecognized role for PARP2 in pancreatic cancer (PDAC) progression, showing that its loss impairs tumour growth.👇
Alexandre Calon retweeted
🔬What if we could predict who will respond to immunotherapy in colorectal cancer?
🧬New biomarker (CTHRC1) led by @Calon_Alex @HMar_research & @BatlleLab @IRBBarcelona
👩⚕️With @ClaraMontagut & @mariglesiascoma
📊Read the full article: hospitaldelmar.cat/en/notici…
@hmarpath @CIBER_ISCIII
Alexandre Calon retweeted
🔬CTHRC1 identified as key biomarker in colorectal cancer
🧬Led by @Calon_Alex @HMar_research & @BatlleLab @IRBBarcelona
📊Validated in ~3,000 patients
🧪With @ClaraMontagut & @mariglesiascoma
👉Study: researchmar.net/news/view.ph…
@hmarpath @CIBER_ISCIII
📢 Published in @Gut_BMJ! We define CTHRC1-CAFs as a #biomarker of clinical outcome and response to #immunotherapy in MSS and MSI #colorectal #cancer.
gut.bmj.com/content/early/20…
@mariglesiascoma @Calon_Alex @BatlleLab @ClaraMontagut @hospitaldelmar @HMar_research @IRBBarcelona
Alexandre Calon retweeted
La revista @Nature selecciona un estudi liderat per
@PNavarro_Lab com un dels sis més destacats de l’any en #càncerdepàncrees
👉researchmar.net/noticies/141…
#TalentMAR
@CancerCSIC @iibbcsic
Alexandre Calon retweeted
La Fundació ”la Caixa” atorga una ajuda a un projecte liderat pel Dr. @Calon_Alex
Un projecte per avançar en el coneixement de l'entorn tumoral en #càncercòlon i recte
@CanalUGR @uniovi_info @cnag_eu #HealthResearch #FundaciólaCaixa
researchmar.net/noticies/140…
Alexandre Calon retweeted
⭐️La Fundació ”la Caixa” atorga una ajuda de prop 1M€ per a un projecte de càncer de còlon amb participació del CNAG!
La iniciativa està liderada pel Dr. @Calon_Alex (@HMar_research), amb suport d'organismes com @CanalUGR i @uniovi_info
researchmar.net/noticies/140…
#FundaciólaCaixa
Alexandre Calon retweeted
La Fundación ”la Caixa” otorga una ayuda a un proyecto liderado por el Dr. @Calon_Alex
Pretende avanzar en el conocimiento del entorno tumoral en #cáncercolon y recto
@CanalUGR @uniovi_info @cnag_eu @CaixaResearchCA #HealthResearch #FundaciónlaCaixa
hospitaldelmar.cat/ca/notici…
💡Chemists, physicists, biologists, clinicians, and computational scientists — 4 teams, one vision: bringing new hope to people facing colorectal cancer.
Thanks to @FundlaCaixa / Health Research Call 2025.
@CanalUGR @uniovi_info @cnag_eu @CaixaResearch @HMar_research
Alexandre Calon retweeted
⚫Si eres médico e investigas en cáncer, ASEICA-Med es tu comunidad
📽️Te lo cuenta @JLinaresA (@hospitaldelmar)
Te esperamos en el RETREAT #ASEICAMed
📅7OCT
🏟️Bilbao-San Mames
‼️ Posibilidad de Registro único o a todo el #ASEICACongress
aseica.es/aseicamed-retreat
Alexandre Calon retweeted
🔥Just out in @NatureCancer!
✅ TAV16, our tumor-agnostic WES-based assay, ranks among the best for MRD detection.
✅ Immune evasion as the main driver progression in MSS CRC, opening new avenues for ICIs.
🙏@_SEOM @GrupoTTD @SaludISCIII @GVAclinic
nature.com/articles/s43018-0…
Alexandre Calon retweeted
🧑🔬Identifican un nuevo factor que determina la agresividad del cáncer de páncreas
👩🔬Equipos del @iibbcsic y el @HMar_research demuestran el papel clave de una proteína en el núcleo de las células que rodean el tumor
👉 tiny.cc/rllg001
Alexandre Calon retweeted
Alexandre Calon retweeted
Les ajudes a la #recerca de @ContraCancerBCN han seleccionat 3 projectes de @HMar_research, liderats per Lluís Espinosa, @JLinaresA i @ClaraMontagut
També un projecte @IRBBarcelona amb participació de la Dra. @SoniaServitja
#CancerResearch #TalentMAR
hospitaldelmar.cat/ca/notici…
🚨 New publication from our lab! A fantastic collaboration between @HMar_research and @IBECBarcelona
Paper alert! 📢 With the @XavierTrepat lab, we have developed MIRO, an #invitro platform to recreate #Cancer cells interactions with their microenvironment to test new #Immunotherapy strategies.
nature.com/articles/s41467-0…
@HMar_research @hospitaldelmar @IBECBarcelona @NatureComms
Alexandre Calon retweeted
Paper alert! 📢 With the @XavierTrepat lab, we have developed MIRO, an #invitro platform to recreate #Cancer cells interactions with their microenvironment to test new #Immunotherapy strategies.
nature.com/articles/s41467-0…
@HMar_research @hospitaldelmar @IBECBarcelona @NatureComms































